Ted Budd

This bill would create a new program called the "United States-Israel Defense Technology Cooperation Initiative." It aims to speed up how the US and Israel work together on defense technology, from research to getting it into military use. This means faster access to advanced tools for both countries' defense, with $150 million authorized each year for three years to pay for it.

This bill would create a new job training program called 'employer-directed skills development.' Businesses could work with local boards to design training for their specific needs, promising to hire trainees who finish. Employers would share training costs based on their size, giving individuals a clearer path to a job.

Federal agencies would check on certain banks less often under this bill. Currently, banks with more than $3 billion in assets get checked every year. This bill would raise that limit to $6 billion. This means banks with assets between $3 billion and $6 billion would only need a check-up at least once every 18 months, instead of every year.

This bill helps job seekers by letting workforce centers go online or be shared by nearby towns. It also allows these centers to open at public colleges, making help easier to find.

This bill would make it illegal to knowingly share private information about special operations personnel or their immediate families if the goal is to threaten, intimidate, or cause violence. This new rule would protect military members, certain Department of Defense employees, and federal law enforcement officers who work with special operations. Those who break this law could face fines and prison time.

This bill would block people who have committed religious freedom violations from getting U.S. visas. It would also require the government to publicly share the names of these individuals and where the violations happened. This aims to keep those involved in such acts from entering the U.S.

This bill would require the Food and Drug Administration (FDA) to update its inspection methods for companies that make biosimilar drugs. This means the FDA would use more remote checks and create a plan to improve inspections at U.S. factories. These updates would improve how the FDA checks on these medicines.

Summary pending...

Summary pending...

Summary pending...

Summary pending...

Summary pending...